Literature DB >> 18725027

Safety of outpatient kidney biopsy: one center's experience with 178 native kidney biopsies.

Manohar Bairy, Khalid Beleed, Alan T Webb, Sunil Bhandari.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18725027     DOI： 10.1053/j.ajkd.2008.06.019

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  5 in total

1.  Outpatient versus inpatient observation after percutaneous native kidney biopsy: a cost minimization study.

Authors:  Saugar Maripuri; David F Penson; T Alp Ikizler; Kerri L Cavanaugh
Journal:  Am J Nephrol       Date:  2011-06-14       Impact factor: 3.754

2.  Value of Immediate Post-Kidney Biopsy Ultrasound in Excluding Late Hemorrhagic Complications.

Authors:  Alian Al-Balas; Ammar Almehmi; Michael Allon
Journal:  Kidney360       Date:  2020-06-23

3.  Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort.

Authors:  Dario Roccatello; Savino Sciascia; Daniela Rossi; Carla Naretto; Mario Bazzan; Laura Solfietti; Simone Baldovino; Elisa Menegatti
Journal:  BMJ Open       Date:  2017-06-21       Impact factor: 2.692

4.  Kidney biopsy guidebook 2020 in Japan.

Authors:  Yoshifumi Ubara; Takehiko Kawaguchi; Tasuku Nagasawa; Kenichiro Miura; Takayuki Katsuno; Takashi Morikawa; Eiji Ishikawa; Masao Ogura; Hideki Matsumura; Ryota Kurayama; Shinsuke Matsumoto; Yuhji Marui; Shigeo Hara; Shoichi Maruyama; Ichiei Narita; Hirokazu Okada; Kazuhiko Tsuruya
Journal:  Clin Exp Nephrol       Date:  2021-04       Impact factor: 2.801

5.  A nationwide survey on clinical practice patterns and bleeding complications of percutaneous native kidney biopsy in Japan.

Authors:  Takehiko Kawaguchi; Tasuku Nagasawsa; Kazuhiko Tsuruya; Kenichiro Miura; Takayuki Katsuno; Takashi Morikawa; Eiji Ishikawa; Masao Ogura; Hideki Matsumura; Ryota Kurayama; Shinsuke Matsumoto; Yuhji Marui; Shigeo Hara; Shoichi Maruyama; Ichiei Narita; Hirokazu Okada; Yoshifumi Ubara
Journal:  Clin Exp Nephrol       Date:  2020-03-18       Impact factor: 2.801
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.